Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Allergan "Even and Dark Spot Cream $88.00

<< Previous

Bullboard Posts

Next >>

Comment by Patiencemysonon Sep 29, 2023 2:07pm

108 Views

Post# 35662201

RE:RE:Allergan "Even and Dark Spot Cream $88.00

I would like ot know how long the product has been out. It just seems that they have something that works well. Maybe they wait out cash strapped Sirona and scoup up the whole company pennies on the dollar while keeping the product out reach to other competitors.
There isnt enough happening after a full year to make me believe otherwise. If 1067 is so superior why has Allergan moved so slowly to improve their position in this dark spot corrector cream?

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks